Email this article Assessment of factors affecting the probability of hospitalization of COVID-19 patients with concomitant pathology and development of a prognostic model based on them
- Authors: Lizinfeld I.A.1, Pshenichcnaya N.Y.2, Parolina L.E.1, Zhuravlev G.Y.2, Maleev V.V.2, Akimkin V.G.2
-
Affiliations:
- National Medical Research Center of Phthisiopulmonology and Infectious Diseases
- Central Research Institute of Epidemiology
- Issue: Vol 94, No 1 (2022)
- Pages: 57-63
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/104759
- DOI: https://doi.org/10.26442/00403660.2022.01.201323
- ID: 104759
Cite item
Full Text
Abstract
Introduction. Currently, a significant number of patients with COVID-19 require inpatient treatment. At the same time, predictors of hospitalization are still stable, including in persons with concomitant pathology.
Aim. Assessment of factors affecting the probability of hospitalization of COVID-19 patients with concomitant pathology and the development of a prognostic model based on them.
Materials and methods. An observational retrospective cohort study of 74 314 patients with COVID-19 with various comorbidities was carried out in the period from March to November 2020 in the Russian Federation.
Results. Based on 16 factors, including age, gender, place of diagnosis, fever, rhinitis, loss of taste, shortness of breath, concomitant diseases of the cardiovascular, bronchopulmonary system, oncological, endocrine diseases in patients included in the study, a prognostic model was developed. The need for inpatient treatment of patients with COVID-19 and comorbidities was determined.
Conclusion. The constructed predictive model has demonstrated sufficient efficiency to assess the likelihood of hospitalization of patients with COVID-19 by medical specialists.
Full Text
##article.viewOnOriginalSite##About the authors
Irina A. Lizinfeld
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Author for correspondence.
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0002-8114-1002
науч. сотр.
Russian Federation, MoscowNatalia Yu. Pshenichcnaya
Central Research Institute of Epidemiology
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0003-2570-711X
д-р мед. наук, проф., зам. дир. по клинико-аналитической работе
Russian Federation, MoscowLiubov E. Parolina
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0003-4365-5894
д-р мед. наук, проф., рук. Центра образования
Russian Federation, MoscowGrigorii Yu. Zhuravlev
Central Research Institute of Epidemiology
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0003-2467-7000
ординатор 2-го года по специальности «Инфекционные болезни»
Russian Federation, MoscowViktor V. Maleev
Central Research Institute of Epidemiology
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0001-5748-178X
акад. РАН, д-р мед. наук, проф., советник дир. по научной работе
Russian Federation, MoscowVasiliy G. Akimkin
Central Research Institute of Epidemiology
Email: pshenichnaya@yandex.ru
ORCID iD: 0000-0003-4228-9044
акад. РАН, д-р мед. наук, проф., дир.
Russian Federation, MoscowReferences
- Zou X, Li S, Fang M, et al. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019. Crit Care Med. 2020;48(8):e657-65. doi: 10.1097/CCM.0000000000004411
- Moreno-Pérez Ó, Andrés M, León-Ramirez JM, et al. The COVID-GRAM Tool for Patients Hospitalized With COVID-19 in Europe. JAMA Intern Med. 2021;181(7):1000-1. doi: 10.1001/jamainternmed.2021.0491
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020 Apr;8(4):e26]. Lancet Respir Med. 2020;8(5):475-81. doi: 10.1016/S2213-2600(20)30079-5
- Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458-64. doi: 10.15585/mmwr.mm6915e3
- Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966
- Killerby ME, Link-Gelles R, Haight SC, et al. Characteristics Associated with Hospitalization Among Patients with COVID-19 – Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):790-4. doi: 10.15585/mmwr.mm6925e1
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3
- Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [published correction appears in JAMA. 2021 May 25;325(20):2120]. JAMA. 2020;323(16):1574-81. doi: 10.1001/jama.2020.5394
- Imam Z, Odish F, Gill I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;288(4):469-76. doi: 10.1111/joim.13119
- Cecconi M, Piovani D, Brunetta E, et al. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. J Clin Med. 2020;9(5):1548. doi: 10.3390/jcm9051548
- CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) – United States, February 12 – March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346. doi: 10.15585/mmwr.mm6912e2
- Soares RCM, Mattos LR, Raposo LM. Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, Brazil. Am J Trop Med Hyg. 2020;103(3):1184-90. doi: 10.4269/ajtmh.20-0483
- Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262
- Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-8. doi: 10.1016/j.jaci.2020.04.006
- Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810-17. doi: 10.1093/eurheartj/ehaa373
- Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-70. doi: 10.1016/S0140-6736(20)31189-2
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published correction appears in JAMA. 2021 Mar 16;325(11):1113]. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585
- Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [published correction appears in BMJ. 2020 Mar 31;368:m1295]. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091
- Chen Y, Zhang K, Zhu G, et al. Clinical characteristics and treatment of critically ill patients with COVID-19 in Hebei. Ann Palliat Med. 2020;9(4):2118-30. doi: 10.21037/apm-20-1273
- Zhu Z, Cai T, Fan L, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332-9. doi: 10.1016/j.ijid.2020.04.041
Supplementary files
